Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alcon (ALC – Research Report) and Edwards Lifesciences (EW – Research Report). Alcon (ALC) BTIG analyst Ryan Zimmerman maintained a Buy rating on Alcon today and set a price target of $80.00. The company's shares closed last Friday at $66.85, close to its 52-week low of $63.92. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alcon-alc-and-edwards-lifesciences-ew?utm_source=advfn.com&utm_medium=referral